| Financial Year |
March 31 2023 |
| Monetary Funds |
371,767,984.31 |
| Held-for-trading Financial Assets |
155,404,405.00 |
| Notes Receivable |
7,455,678.82 |
| Accounts Receivable |
575,822,804.47 |
| Advances to Suppliers |
51,199,923.87 |
| Other Receivables |
19,405,213.69 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
353,357,581.79 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
9,657,389.02 |
| Total Current Assets |
1,547,638,179.39 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,425,459,944.46 |
| Investment Properties |
264,142,070.58 |
| Fixed Assetes |
2,587,881,759.32 |
| Under-construction Projects |
342,261,478.65 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
297,634,080.25 |
| R&D expenses |
6,723,537.60 |
| Goodwill |
24,557,825.67 |
| Long-Term Deferred and Prepaid Expenses |
54,351,733.16 |
| Deferred Income Tax Assets |
71,603,180.80 |
| Other Non-Current Assets |
47,760,550.85 |
| Sub-Total of Non-Current Assets |
5,391,768,000.29 |
| Total Assets |
6,939,406,179.68 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
17,557,084.18 |
| Accounts Payable |
352,668,980.14 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
8,200,667.96 |
| Taxes Payable |
22,793,887.39 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
259,974,518.39 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
411,839,380.31 |
| Other Current Liabilities |
5,146,759.28 |
| Sub-Total of Current Liabilities |
1,184,661,997.23 |
| Long-term Loans |
1,459,542,086.39 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
25,632,830.10 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,546,654,292.27 |
| Total Liabilities |
2,731,316,289.50 |
| Paid-In Capital(Or Share Stock) |
756,791,003.00 |
| Capital Surplus |
1,941,880,754.67 |
| Surplus Reserve |
165,774,742.25 |
| LESS:Treasury Stock |
200,012,057.47 |
| Undistributed Profits |
1,504,752,014.49 |
| Minority Stockholder's Interest |
13,980,058.38 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,194,109,831.80 |
| Owner's Equity（Stockholder's Equity） |
4,208,089,890.18 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,939,406,179.68 |
